What is OncoDNA?
Founded in 2012 and headquartered in Belgium, OncoDNA is dedicated to advancing cancer care by providing comprehensive molecular profiling services. The company's core objective is to enable personalized therapy decisions for individual patients, leveraging cutting-edge genomic and proteomic analysis. By offering detailed insights into a tumor's molecular landscape, OncoDNA empowers oncologists and researchers to select the most effective treatment strategies, thereby improving patient outcomes and driving innovation in oncology.
How much funding has OncoDNA raised?
OncoDNA has raised a total of $28.6M across 2 funding rounds:
Series A
$8.6M
Series B
$20M
Series A (2016): $8.6M, investors not publicly disclosed
Series B (2020): $20M led by Sambrinvest, Swisscanto Invest, Inventures, SRIW, Vesalius Biocapital III, The SFPI-FPIM, CPH Bank, and Sofinim
Key Investors in OncoDNA
Sambrinvest
Sambrinvest is a private financial partner based in the Charleroi Métropole, specializing in financing small and medium-sized enterprises (SMEs). With a portfolio of over 300 companies, it offers tailored financing solutions to meet diverse business needs. The company is committed to creating impactful projects and has a strategic plan in place for the next three years. Sambrinvest supports various sectors, including real estate, automotive, and life sciences, and has a significant role in the Belgian market.
Inventures
Spreds is a leading crowdfunding platform in Belgium that empowers private investors to invest in high-potential start-ups, scale-ups, local authorities, and renewable energy producers. Established in 2011, it offers a structured and regulated framework for investment, allowing users to co-invest with business angels and venture capitalists. The platform provides a range of investment opportunities while ensuring security and transparency through pre-selected investments and a dedicated subsidiary, Spreds Finance. Additionally, Spreds offers tax reduction benefits for investors, making it an attractive option for those looking to support entrepreneurship and minimize their ecological footprint.
SRIW
Wallonie Entreprendre is the economic and financial tool of Wallonia, dedicated to supporting the entrepreneurial fabric of the region. The organization provides various services including financing, guarantees, and expertise to foster sustainable growth and job creation. It focuses on emerging sectors such as digital, deep tech, social economy, and healthcare, while adhering to social and environmental standards. As a financial partner, Wallonie Entreprendre invests in the growth and sustainability of businesses to shape the future of Wallonia.
What's next for OncoDNA?
The substantial enterprise-level funding and recent strategic investment position OncoDNA for accelerated growth and market expansion. This capital infusion is expected to fuel further research and development, enhance its technological capabilities, and broaden its service offerings. The company is poised to solidify its leadership in the personalized medicine space, potentially exploring new therapeutic areas and strategic partnerships to deepen its impact on cancer treatment globally. OncoDNA's trajectory suggests a focus on scaling its operations and further integrating its profiling solutions into mainstream clinical practice.
See full OncoDNA company page
